Merck's Acquisition of Terns Therapeutics Clears HSR Waiting Period

Merck's proposed acquisition of Terns Therapeutics has successfully passed the expiration of the Hart-Scott-Rodino (HSR) antitrust waiting period, moving the deal closer to completion.